Dare Bioscience, Inc. (DARE) financial statements (2022 and earlier)

Company profile

Business Address 3655 NOBEL DRIVE
SAN DIEGO, CA 92122
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments51,6744,6694,7806,8067,56034,950
Cash and cash equivalents51,6744,6694,7806,8067,56034,950
Receivables1,14546055531284 
Prepaid expense2,4771,8541,109403312 
Other current assets    193 
Other undisclosed current assets     1,840
Total current assets:55,2966,9846,4447,2408,34936,790
Noncurrent Assets
Property, plant and equipment2638649 668
Intangible assets, net (including goodwill)    5,188 
Goodwill    5,188 
Other noncurrent assets485529935578723230
Total noncurrent assets:5115679995875,911898
TOTAL ASSETS:55,8077,5517,4437,82714,26037,688
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1363,3602,0996319676,057
Accounts payable    3081,446
Accrued liabilities    3424,611
Employee-related liabilities1,5331,157715416316 
Other undisclosed accounts payable and accrued liabilities1,6032,2031,383215  
Debt 367411  8,382
Business combination, contingent consideration, liability 1,000    
Deferred revenue and credits 2,500
Other undisclosed current liabilities12,9172,9343,103460  
Total current liabilities:16,0537,6615,6121,09196716,939
Noncurrent Liabilities
Long-term debt and lease obligation     4,439
Long-term debt, excluding current maturities     4,439
Liabilities, other than long-term debt1,0001,0421,3901003,199
Deferred revenue and credits01,993
Deferred revenue1,0001,000 
Deferred rent credit   10
Other liabilities 42390  1,206
Business combination, contingent consideration, liability  1,000   
Total noncurrent liabilities:1,0001,0421,3901007,638
Total liabilities:17,0538,7027,0021,10196724,577
Stockholders' equity
Stockholders' equity attributable to parent38,754(1,152)4416,72713,29313,111
Common stock842113
Additional paid in capital149,02870,36644,56535,79225,541213,788
Accumulated other comprehensive loss(155)(91)(103)(97)(18) 
Accumulated deficit(110,127)(71,431)(44,023)(28,970)(12,231)(200,680)
Total stockholders' equity:38,754(1,152)4416,72713,29313,111
TOTAL LIABILITIES AND EQUITY:55,8077,5517,4437,82714,26037,688

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues     766
Gross profit:     766
Operating expenses(39,069)(27,402)(14,345)(16,882)(11,180)(37,920)
Operating loss:(39,069)(27,402)(14,345)(16,882)(11,180)(37,154)
Nonoperating income (expense)3281143 (2,151)
Other nonoperating income3281143  
Interest and debt expense370   (323)(2,237)
Other undisclosed loss from continuing operations before equity method investments, income taxes (0)(0)(75)(18) 
Loss from continuing operations before equity method investments, income taxes:(38,696)(27,401)(14,264)(16,814)(11,521)(41,542)
Other undisclosed income from continuing operations before income taxes0     
Loss from continuing operations before income taxes:(38,696)(27,401)(14,264)(16,814)(11,521)(41,542)
Income tax expense   (3)  
Net loss:(38,696)(27,401)(14,264)(16,817)(11,521)(41,542)
Other undisclosed net income (loss) attributable to parent(0)0078182,237
Net loss attributable to parent:(38,696)(27,401)(14,264)(16,739)(11,503)(39,305)
Preferred stock dividends and other adjustments (7)(790)   
Net loss available to common stockholders, diluted:(38,696)(27,408)(15,053)(16,739)(11,503)(39,305)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(38,696)(27,401)(14,264)(16,817)(11,521)(41,542)
Comprehensive loss:(38,696)(27,401)(14,264)(16,817)(11,521)(41,542)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(64)5(795)(0)(0) 
Comprehensive loss, net of tax, attributable to parent:(38,760)(27,396)(15,059)(16,817)(11,521)(41,542)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: